ARTICLE | Financial News
Partner Therapeutics raises $60M, in-licenses Leukine
February 2, 2018 12:38 AM UTC
Newco Partner Therapeutics Inc. (Boston, Mass.) raised $60 million on Thursday in a series A round led by Perceptive Advisors and also gained rights to Leukine sargramostim from Sanofi (Euronext:SAN; NYSE:SNY). Fellow new investors Adams St. Partners and MidCap Financial also participated in the round as did members of management.
The company, which launched on Jan. 25, plans to use this initial financing to acquire a cancer-focused portfolio of approved and late-stage therapies...
BCIQ Target Profiles
Granulocyte macrophage colony-stimulating factor (GM-CSF) (CSF2)